Amedisys Shares Soar 3.21% on Strong Q1 Earnings

Amedisys (AMED) shares surged 3.21% intraday, reaching their highest level since November 2024, marking a third consecutive day of gains with a total increase of 2.04% over the past three days.

Amedisys reported its financial results for the first quarter of 2025, posting a profit of $61 million and earnings per share (EPS) of $1.84. This performance indicates a profitable quarter, with earnings increasing compared to the same period last year and surpassing Wall Street estimates.

Despite the strong EPS performance, the company's revenue of $594.8 million slightly missed estimates, presenting a mixed financial outcome for the period. This discrepancy between earnings and revenue may have contributed to the stock's recent volatility.

On April 17, 2025, Amedisys extended its credit facility amid merger discussions. This move could impact the company's financial flexibility and strategic opportunities, potentially influencing investor sentiment and stock price movements.